DataMEDS AI (MEDS)
Pharmaceutical distributor, pharmacy operator and prescription-routing technology provider.
Something off on this page? Send us feedback.
Sells pharmaceuticals wholesale, dispenses prescriptions and provides logistics services, while its EinsteinRx hub routes and supports prescription fulfillment. Revenue is transaction-based across distribution, pharmacy sales and 3PL fees; its AI, blockchain and consumer-health additions remain under integration or rollout.
Combines pharmaceutical wholesale distribution, prescription fulfillment and technology-enabled clinical services in the United States. Wellgistics distributes branded and generic drugs and over-the-counter products to independent pharmacies, while Corexa Pharmacy fills and ships prescriptions. The company also earns 3PL fees for warehousing, inventory management, pick/pack and shipping for manufacturers.
EinsteinRx routes prescriptions between patients, prescribers, pharmacies, payors/PBMs and manufacturers while supporting eligibility verification, onboarding, adherence, prior authorization and cash-pay fulfillment. PharmacyChain and the Health Lives Here app are being integrated into that workflow, with broad public rollout of the app planned on a state-by-state basis.
Depends on pharmacy and wholesale licenses, PBM and insurer reimbursement, provider-network inclusion, product access, third-party technology services, and sustained working capital for inventory purchasing and fulfillment.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $2.5M · Total debt $32.6M · Total assets $32.8M · Shareholders' equity −$19.5M
- Revenue
- $1.8M
- Operating income
- −$7.3M
- Net income
- −$18.4M
No dividends on record.
No ownership filings on record for this listing.
- McKesson
Largest wholesale and pharmaceutical-services threat.
- Cencora
Scaled drug distributor with broad pharma-services overlap.
- Cardinal Health
Large pharmaceutical and specialty distribution rival.
- CVS Health
Integrated retail, specialty, PBM and virtual-care threat.
- Amazon
Digital pharmacy and fast prescription-delivery rival.
- Hims & Hers Health
Digital GLP-1 care and prescription-fulfillment challenger.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| DataMEDS AI | $4.28 | +2.27% | $11.0M | — | — | 1.4 | −77.2% |
| McKesson | $893.79 | +0.83% | $103.79B | 23.7 | 19.3 | 0.3 | +7.7% |
| Cencora | $316.24 | −0.08% | $61.58B | 23.5 | 16.3 | 0.2 | +5.1% |
| Cardinal Health | $226.47 | +0.32% | $52.87B | 31.2 | 18.1 | 0.2 | +5.8% |
| CVS Health | $87.68 | +0.09% | $111.77B | 23.2 | 10.8 | 0.3 | +7.3% |
| Amazon | $254.59 | −1.50% | $2.78T | 20.8 | 27.3 | 3.6 | +19.6% |
| Hims & Hers Health | $31.42 | +7.04% | $6.55B | — | 146.1 | 2.5 | +38.3% |
| Median | 23.5 | 18.7 | 0.3 | +7.5% |